by OmegaQuant | Jul 10, 2019 | Heart Health, Omega-3s, Prenatal DHA, Research
The US Food and Drug Administration (FDA) has made some bold moves in the last month regarding omega-3s by (1) – supporting health claims linking these important nutrients with a reduction in blood pressure, and (2) – updating its advice to women about the...
by OmegaQuant | Jun 27, 2019 | Brain Health, EPA & DHA, Prenatal DHA, Research
Research published in the June issue of Pediatrics shows that American children don’t eat enough seafood, which could have a negative impact on their health. This is because they are missing out on important fatty acids like omega-3s EPA and DHA, which contribute...
by OmegaQuant | Jun 18, 2019 | EPA & DHA, Omega-3 Index, Omega-3s, Prenatal DHA, Research
Doctors must be very disciplined when offering advice and recommendations during pregnancy. Many times, you, the patient, could be more knowledgeable about things like nutrition and diet. This is not unusual. Besides taking some required nutrition classes during their...
by OmegaQuant | Jun 11, 2019 | Brain Health, Cognitive Health, Omega-3 Index, Omega-3s
Every day, there seems to be a new article about the growing popularity of CBD oil. Some articles speculate on the enormous economic growth that is expected from CBD products over the next few years, while others focus on CBD’s potential for reducing chronic pain and...
by OmegaQuant | Jun 5, 2019 | Omega-3 Index, Prenatal DHA
In February, OmegaQuant launched the first-ever Prenatal DHA Test for consumers and health practitioners to help guide the intake of the omega-3 DHA, which is an important nutrient women need before, during and after pregnancy. Alongside this effort, OmegaQuant...
These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.
